Net earnings per share for the last 12 months: Generation Bio Co. (GBIO)

GBIO (Generation Bio Co.) - company brandmark

The absence of dividends is offset by Generation Bio Co. (GBIO) holding first-mover status in non-viral therapy, which grants the company pricing power. The 12-month earnings per share history serves as a confidence indicator, where the current value equals -9.36. Growth is driven by partnerships with pharma behemoths and the success of the eDNA platform, as well as the development of ctLNP for the delivery of large genes without an immune response.

GBIO (Generation Bio Co.) Net earnings per share for the last four quarters history from 07/04/2022 to 02/21/2026

Financial and market metric breakdowns for Generation Bio Co (GBIO)

- stock price and consensus target price:
Stock Price Generation Bio Corp|GBIO - Analyst Consensus Forecast
- company stock exchange capitalization indicators:
Market Valuation Generation Bio Co.|GBIO - Aggregate Business Value
- balance sheet net asset value indicators:
Book Value per Share Generation Bio|GBIO - Book Valuation of Business|Market Value to Book Value Ratio generationbio.com|GBIO - Company Assets
- business debt structure and liquidity details:
Debt to Equity Generation Bio Co.|GBIO - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Ratio Generation Bio Corp|GBIO - Aggregate Debt Obligations|Debts to Book Capitalization Generation Bio Co.|GBIO - Company Long-Term Debt|Company Short-Term Debts Generation Bio|Quick Liquidity generationbio.com
- net income and valuation multiples indicators:
GBIO - Company Net Income|Future Profit Generation Bio Co.|GBIO - Company Value to Net Income|Forward P/E Multiple Generation Bio Corp|GBIO - Price/Earnings to Growth Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Generation Bio Co.|GBIO - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Generation Bio|GBIO - Net earnings per share for the last four quarters|Quarterly EPS earnings growth generationbio.com|GBIO - Net earnings per share change in current year|Earnings growth forecast for next year Generation Bio Co.
General company analysis:generationbio.com (GBIO)
Mass-produced product of Generation Bio Co.

Assessing real business returns is critical for capital protection amid volatility. This indicator aggregates net income over the last four quarters, allocating it per share to determine the fundamental value of a stake. By analyzing the EPS TTM dynamics of Generation Bio Co. (GBIO), an investor can discern the actual financial result stripped of market noise. Negative values here are often driven by high costs associated with the cryogenic transportation of drugs. Expensive specialized logistics directly impact the final profitability of each share.

Competitor analysis for Generation Bio Co.

Tempus AI - Net earnings per share (EPS TTM)|QGEN - Net earnings per share (EPS TTM)|IONS (Ionis) - Net earnings per share for the last 12 months|RGEN: Earnings per share for the last four quarters|RNA (Avidity) - Net earnings per share (EPS TTM)|CRISPR (CRSP) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months GeneDx Holdings Corp. (WGS)|RARE - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Beam Therapeutics BEAM|SRPT: Earnings per share for the last 12 months|TWST: Net earnings per share for the last 12 months|Earnings per share for the trailing year TXG (10x)|NTLA: Net earnings per share (EPS TTM)|STOK (stoketherapeutics.com) - Earnings per share for the last twelve months|BLFS (BioLife Solutions) - Net earnings per share (EPS TTM)|Wave Life Sciences Ltd (WVE) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Maze Tx (MAZE)|SION - Net earnings per one share for the last twelve months|Prime Medicine, Inc. - Net earnings per share for the last 12 months|Earnings per share for the trailing year TSHA|uniQure - Net earnings per share (EPS TTM)|MeiraGTx Holdings (MGTX) - Net earnings per share for the last 12 months|Regenxbio (RGNX) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Solid Corp (SLDB)|Net earnings per share for the last 12 months OCGN|pacb.com (PACB) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) BNTC|Design Therapeutics Inc (DSGN) - Net earnings per share for the trailing year|Net earnings per share (EPS TTM) RCKT (Rocket Pharmaceuticals Inc)|4D Molecular Corp - Earnings per share for the last twelve months|Lexeo - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Korro Bio, Inc. KRRO|Editas Medicine (EDIT) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Silence Therapeutics PLC (SLN)|PRQR (ProQR) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months CDXS (Codexis Bio)|Earnings per share for the last twelve months Sangamo Therapeutics (SGMO)|nautilus.bio - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) MGX (Metagenomi)|Net earnings per share (EPS TTM) Precision BioSciences Inc. DTIL|Boundless Bio, Inc - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Exicure, Inc. (XCUR)|IMNN: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Phio Pharmaceuticals Corp. (PHIO)|Earnings per share for the last twelve months Mustang Bio Inc|Earnings per share for the last 12 months RNAZ (TransCode)|Net earnings per share (EPS TTM) BNGO|APDN - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months bluebird bio, Inc. BLUE|Earnings per share for the trailing year IPA|Omega Therapeutics, Inc. - Net earnings per share (EPS TTM)|OMIC - Net earnings per share (EPS TTM)|RGLS (Regulus Therapeutics Inc) - Net earnings per share for the last 12 months|SYRS: Earnings per share for the last four quarters|TBIO (Telesis Bio, Inc.) - Net earnings per share (EPS TTM)|traconpharma.com (TCON) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Unity Biotechnology, Inc. (UBX)